Ascenta Capital

Ascenta Capital is focused on biopharma investment and growth.

About Ascenta Capital

Ascenta Capital is a Financial Services company. Ascenta Capital is focused on biopharma investment and growth. It operates on a Commission-Based model. Ascenta Capital offers products and services including Investment in Biopharma. Its focus areas include Investment Management and Venture Capital.

Company details

Ascenta Capital is engaged in supporting innovative biopharma companies by providing concentrated investments. The focus is placed on translating scientific foundations into clinical development of medicines for patients. Partnerships are formed with companies before clinical proof of concept, aiding in early human safety and efficiency data. Opportunities are also seen in multi-product platforms where complex growth and value creation strategies are addressed. The sector of operation is primarily biopharma, leveraging the global convergence of biological insights, life science technology, and data analytics.

  • Sectors
    Financial Services
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ascentacap.com

Products & Services of Ascenta Capital

Ascenta Capital offers a comprehensive portfolio of products and services, including Investment in Biopharma.

Investment in Biopharma
Financial Services

Investments are made in innovative biopharma companies.

People of Ascenta Capital

5 people are tracked at Ascenta Capital (3 in leadership, 2 in team).

NameRoleGroup
Paul Deutsch
Advisory PartnerLeadership
Lorence Kim
Co-founder and Managing PartnerLeadership
David Shields
Chief Financial OfficerLeadership
John Gutierrez
Senior AssociateTeam
Nancy McAdams
Executive AssistantTeam
Premium access

Complete people profiles for Ascenta Capital

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ascenta Capital

Ascenta Capital is engaged in supporting innovative biopharma companies by providing concentrated investments. The focus is placed on translating scientific foundations into clinical development of medicines for patients. Partnerships are formed with companies before clinical proof of concept, aiding in early human safety and efficiency data. Opportunities are also seen in multi-product platforms where complex growth and value creation strategies are addressed. The sector of operation is primarily biopharma, leveraging the global convergence of biological insights, life science technology, and data analytics.

Ascenta Capital offers Investment in Biopharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available